MedPath

Evaluation of the effect of modified Xingpiyiwei Decoction combined with peck acupuncture on the prevention of metachronous early gastric cancer

Not Applicable
Conditions
gastric cancer
Registration Number
ITMCTR2200006031
Lead Sponsor
Peking University First Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Between the ages of 40 and 70 years.
(2) Surgical pathological criteria for early gastric cancer.
(3) Breath test confirmed H. pylori as uninfected or post-decontamination status.
(4) Not taking any type of post-operative gastric medication or currently off medication for more than 1 month.
(5) Stable local residence with no plans to move within the last 2 years.
(6) Conscious and capable of autonomous behaviour and can cooperate with the implementation of the intervention.
(7) Consent to participate in this study.

Exclusion Criteria

(1) Patients with other systemic neoplastic disease or a history of neoplastic disease.
(2) Patients with serious co-morbidities that may prevent safe participation in the intervention.
(3) Patients who have had an acute serious cardiovascular or cerebrovascular event, severe trauma or major post-operative surgery within six months.
(4) Patients with definite hepatic or renal insufficiency.
(5) Patients who are pregnant and lactating, allergic and have a history of allergy to drug components.
(6) Patients who have participated in other clinical interventional studies within the last 3 months.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OLGA Score;OLGIM Score;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath